检索结果 - Tim Hardman
- Showing 1 - 4 results of 4
-
1
The New First-in-Human EMA Guideline: Disruptive or Constructive? Outcomes From the First EUFEMED Discussion Forum 由 Kerstin Breithaupt-Grögler, Tim Hardman, Tim Hardman, Jan de Hoon, Yves Donazzolo, Sylvie Rottey, Hildegard Sourgens, Steffan Stringer
出版 2019索引号: 载入...Connect to this object online.
位于: 载入...
图书 -
2
European Federation for Exploratory Medicines Development Lyon Conference 2019: The Changing Landscape of Early Medicines Development-Be Prepared 由 Tim Hardman, Henri Caplain, Sylvie Rottey, Desiree Douglas, Steffan Stringer, Hildegard Sourgens
出版 2019索引号: 载入...Connect to this object online.
位于: 载入...
图书 -
3
Corrigendum: The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study... 由 Sergey V Efimov, Natallia V Matsiyeuskaya, Olga V Boytsova, Lyudmila Yu Akhieva, Elena I Kvasova, Francisco Harrison, Yulia S Karpova, Anton Tikhonov, Nadezhda F Khomyakova, Tim Hardman, Jean-François Rossi
出版 2021索引号: 载入...Connect to this object online.
位于: 载入...
图书 -
4
The effect of azoximer bromide (Polyoxidonium®) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study 由 Sergey V Efimov, Natallia V Matsiyeuskaya, Olga V Boytsova, Lyudmila Yu Akhieva, Elena I Kvasova, Francisco Harrison, Yulia S Karpova, Anton Tikhonov, Nadezhda F Khomyakova, Tim Hardman, Jean-François Rossi
出版 2021索引号: 载入...Connect to this object online.
位于: 载入...
图书